STOCKHOLM, June 11, 2026 /PRNewswire/ -- Oriflame, the global beauty and wellbeing company, today announces a new partnership with Cirque du Soleil, becoming its...
IRONDALE, Ala., June 10, 2026 /PRNewswire/ -- EWTN Global Catholic Network announced today the acquisition of a majority stake in Holy Habits, a Catholic...
Bold ideas from four local students are among just 60 semifinalist submissions selected from over 3,700 nationwide to pitch at the Mott Million Dollar...
Will Serve Thousands of Long Beach Residents Each Year with Recuperative Care Services and Pathways to Stable HousingSACRAMENTO, Calif., June 10, 2026 /PRNewswire-HISPANIC PR...
PHILADELPHIA, June 10, 2026 /PRNewswire/ -- Following the Philadelphia City Council's vote to pass a bill classifying kratom and hemp-derived products as "intoxicating substances,"...
In the news release, O Positiv Health Releases Its First Prenatal, PREGGO Prenatal + Probiotic, issued 10-Feb-2026 by O Positiv Health over PR Newswire,...
Acquisition expands Nagase America's coatings capabilities with dedicated testing, training, and technical innovation lab in Costa Mesa, CaliforniaITASCA, Ill., June 10, 2026 /PRNewswire/ -- Nagase...
Matthew Williamson Returns to Fashion with Exclusive Free People CapsulePHILADELPHIA, June 10, 2026 /PRNewswire/ -- British designer Matthew Williamson makes his return to fashion...
TEL AVIV, Israel, June 10, 2026 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), today announced the closing of Teva’s acquisition of Emalex Biosciences, strengthening its late-stage pipeline with ecopipam and further advancing its Pivot to Growth strategy. Phase 3 data for ecopipam were recently published in JAMA Neurology, and a U.S. NDA submission is anticipated in the second half of 2026.
Following a second federal trial, a D.C. jury acquitted Guanghua Jin of lead bank fraud conspiracy. Remaining counts were resolved via a plea agreement.